These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2843574)

  • 21. Cholinergic mechanisms in canine narcolepsy--II. Acetylcholine release in the pontine reticular formation is enhanced during cataplexy.
    Reid MS; Siegel JM; Dement WC; Mignot E
    Neuroscience; 1994 Apr; 59(3):523-30. PubMed ID: 8008206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monoaminergic mechanisms and experimental cataplexy.
    Foutz AS; Delashaw JB; Guilleminault C; Dement WC
    Ann Neurol; 1981 Oct; 10(4):369-76. PubMed ID: 6976152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sulpiride, a D2/D3 blocker, reduces cataplexy but not REM sleep in canine narcolepsy.
    Okura M; Riehl J; Mignot E; Nishino S
    Neuropsychopharmacology; 2000 Nov; 23(5):528-38. PubMed ID: 11027918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prazosin increases immobility episodes in taiep rats without changes in the properties of alpha1 receptors.
    Cortés MD; Arias-Montaño JA; Eguibar JR
    Neurosci Lett; 2007 Jan; 412(2):159-62. PubMed ID: 17194536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The neurobiology of narcolepsy-cataplexy syndrome.
    Aldrich MS
    Int J Neurol; 1991-1992; 25-26():29-40. PubMed ID: 11980061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heart rate and blood pressure changes during sleep-waking cycles and cataplexy in narcoleptic dogs.
    Siegel JM; Tomaszewski KS; Fahringer H; Cave G; Kilduff T; Dement WC
    Am J Physiol; 1989 Jan; 256(1 Pt 2):H111-9. PubMed ID: 2912173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nifedipine attenuates both alpha-1 and alpha-2 adrenoceptor-mediated pressor and vasoconstrictor responses in conscious dogs and primates.
    Woodman OL; Constantine JW; Vatner SF
    J Pharmacol Exp Ther; 1986 Dec; 239(3):648-53. PubMed ID: 3025415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exacerbation of human cataplexy by prazosin.
    Aldrich MS; Rogers AE
    Sleep; 1989 Jun; 12(3):254-6. PubMed ID: 2740697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nature of alpha 1 and postjunctional alpha 2 adrenoceptors in the pulmonary vascular bed.
    Hyman AL; Lippton HL; Kadowitz PJ
    Fed Proc; 1986 Aug; 45(9):2336-40. PubMed ID: 3015686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological characterization of alpha adrenoceptors involved in the antinociceptive and cardiovascular effects of intrathecally administered clonidine.
    Solomon RE; Brody MJ; Gebhart GF
    J Pharmacol Exp Ther; 1989 Oct; 251(1):27-38. PubMed ID: 2571720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Central alpha-2 adrenoceptor-mediated hypertensive response to clonidine in conscious, normotensive rats.
    Kawasaki H; Takasaki K
    J Pharmacol Exp Ther; 1986 Mar; 236(3):810-8. PubMed ID: 3005557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of the alpha-adrenoceptors mediating positive inotropy of rat left atria by use of selective agonists and antagonists.
    Williamson KL; Broadley KJ
    Arch Int Pharmacodyn Ther; 1987 Feb; 285(2):181-98. PubMed ID: 2883945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet alpha 2 adrenoceptors in human and canine narcolepsy.
    Valtier D; Nishino S; Guilleminault C; Dement WC; Mignot E
    Biol Psychiatry; 1991 Feb; 29(4):376-82. PubMed ID: 1645207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurochemical studies of human narcolepsy: alpha-adrenergic receptor autoradiography of human narcoleptic brain and brainstem.
    Aldrich MS; Prokopowicz G; Ockert K; Hollingsworth Z; Penney JB; Albin RL
    Sleep; 1994 Oct; 17(7):598-608. PubMed ID: 7846457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Central alpha receptors and their role in digoxin cardiotoxicity.
    Plunkett LM; Tackett RL
    J Pharmacol Exp Ther; 1983 Dec; 227(3):683-6. PubMed ID: 6317844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of alpha-1 and alpha-2 adrenoceptor-mediated vasoconstriction in the in situ, autoperfused, pulmonary circulation of the anesthetized dog.
    Shebuski RJ; Fujita T; Ruffolo RR
    J Pharmacol Exp Ther; 1986 Jul; 238(1):217-23. PubMed ID: 3014116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Developmental changes in CSF hypocretin-1 (orexin-A) levels in normal and genetically narcoleptic Doberman pinschers.
    John J; Wu MF; Maidment NT; Lam HA; Boehmer LN; Patton M; Siegel JM
    J Physiol; 2004 Oct; 560(Pt 2):587-92. PubMed ID: 15308685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of alpha-adrenoceptor agonists on cardiac output and blood pressure in spinally anesthetized ganglion-blocked dogs.
    Yamazaki R; Tsuchida K; Aihara H
    Arch Int Pharmacodyn Ther; 1988; 295():80-93. PubMed ID: 2469405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sleepiness that cannot be overcome: narcolepsy and cataplexy.
    Han F
    Respirology; 2012 Nov; 17(8):1157-65. PubMed ID: 22471619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Integrated treatment of the symptoms of narcolepsy-cataplexy syndrome with sodium oxybate].
    Poza-Aldea JJ
    Rev Neurol; 2009 Jan 1-15; 48(1):27-31. PubMed ID: 19145563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.